Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, ...

Led by an interest in GLP-1 weight loss drugs, more health care brands may advertise in the Super Bowl this year.

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...

Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

How will Feb. 1 tariffs affect you? U.S. figure skater Spencer Lane, 16, shared a photo from inside American Eagle Flight ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...